Timing of Prophylactic Anticoagulation and Its Effect on Thromboembolic Events After Surgery for Metastatic Tumors of the Spine.
Adult
Aged
Anticoagulants
/ administration & dosage
Cohort Studies
Female
Humans
Kyphoplasty
/ adverse effects
Male
Middle Aged
Post-Exposure Prophylaxis
/ methods
Postoperative Complications
/ diagnosis
Prosthesis Implantation
/ adverse effects
Pulmonary Embolism
/ diagnosis
Retrospective Studies
Risk Factors
Spinal Neoplasms
/ diagnosis
Thromboembolism
/ diagnosis
Time Factors
Venous Thromboembolism
/ diagnosis
Venous Thrombosis
/ diagnosis
Journal
Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646
Informations de publication
Date de publication:
01 Jun 2019
01 Jun 2019
Historique:
pubmed:
27
11
2018
medline:
26
7
2019
entrez:
27
11
2018
Statut:
ppublish
Résumé
Retrospective cohort study. To investigate the effect of timing of initiation of prophylactic anticoagulation (AC) on the incidence of venous thromboembolism (VTE) after surgery for metastatic tumors of the spine. VTE is a known complication in patients undergoing surgery for metastatic spine disease. However, there is limited data on the use of prophylactic AC in this population and its impact on the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as the risk of epidural hematoma. A retrospective review of our institutional neurosurgical spine database for the years 2012 through 2018 was performed. Patients who underwent surgery for metastatic tumors were identified. The development of VTE within 30 days was examined, as well as the occurrence of epidural hematoma. The incidence of VTE was compared between patients receiving "early" (within postoperative days 1-3) and "delayed" prophylactic AC (on or after postoperative day 4). Sixty-five consecutive patients were identified (mean age 57, 62% male). The overall rate of VTE was 16.9%-all of whom had DVTs with a 3.1% rate of nonfatal PE (two patients also developed PE). From the overall cohort, 36 of 65 (56%) received prophylactic AC in addition to mechanical prophylaxis-22 in the early group (61.1%) and 14 in the delayed group (38.9%). The risk of VTE was 9.1% in the early group and 35.7% in the delayed group (26.6% absolute risk reduction; P = 0.049); there was one case of epidural hematoma (1.5%). On multivariate analysis, delayed prophylactic AC was found to significantly increase the odds of VTE development (OR 6.43; 95% CI, 1.01-41.2; P = 0.049). The findings of this study suggest that administration of prophylactic AC between days 1 and 3 after surgery for metastatic tumors of the spine may significantly reduce the risk of postoperative thromboembolic events. 4.
Sections du résumé
STUDY DESIGN
METHODS
Retrospective cohort study.
OBJECTIVE
OBJECTIVE
To investigate the effect of timing of initiation of prophylactic anticoagulation (AC) on the incidence of venous thromboembolism (VTE) after surgery for metastatic tumors of the spine.
SUMMARY OF BACKGROUND DATA
BACKGROUND
VTE is a known complication in patients undergoing surgery for metastatic spine disease. However, there is limited data on the use of prophylactic AC in this population and its impact on the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as the risk of epidural hematoma.
METHODS
METHODS
A retrospective review of our institutional neurosurgical spine database for the years 2012 through 2018 was performed. Patients who underwent surgery for metastatic tumors were identified. The development of VTE within 30 days was examined, as well as the occurrence of epidural hematoma. The incidence of VTE was compared between patients receiving "early" (within postoperative days 1-3) and "delayed" prophylactic AC (on or after postoperative day 4).
RESULTS
RESULTS
Sixty-five consecutive patients were identified (mean age 57, 62% male). The overall rate of VTE was 16.9%-all of whom had DVTs with a 3.1% rate of nonfatal PE (two patients also developed PE). From the overall cohort, 36 of 65 (56%) received prophylactic AC in addition to mechanical prophylaxis-22 in the early group (61.1%) and 14 in the delayed group (38.9%). The risk of VTE was 9.1% in the early group and 35.7% in the delayed group (26.6% absolute risk reduction; P = 0.049); there was one case of epidural hematoma (1.5%). On multivariate analysis, delayed prophylactic AC was found to significantly increase the odds of VTE development (OR 6.43; 95% CI, 1.01-41.2; P = 0.049).
CONCLUSION
CONCLUSIONS
The findings of this study suggest that administration of prophylactic AC between days 1 and 3 after surgery for metastatic tumors of the spine may significantly reduce the risk of postoperative thromboembolic events.
LEVEL OF EVIDENCE
METHODS
4.
Identifiants
pubmed: 30475345
doi: 10.1097/BRS.0000000000002944
pii: 00007632-201906010-00008
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Pagination
E650-E655Références
Caine GJ, Stonelake PS, Lip GY, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002; 4:465–473.
Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004; 9:188–196.
Pascal-Moussellard H, Broc G, Pointillart V, et al. Complications of vertebral metastasis surgery. Eur Spine J 1998; 7:438–444.
Lau D, Leach MR, Than KD, et al. Independent predictors of complication following surgery for spinal metastasis. Eur Spine J 2013; 22:1402–1407.
Patil CG, Lad SP, Santarelli J, et al. National inpatient complications and outcomes after surgery for spinal metastasis from 1993-2002. Cancer 2007; 110:625–630.
Jansson KA, Bauer HC. Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J 2006; 15:196–202.
Dea N, Versteeg A, Fisher C, et al. Adverse events in emergency oncological spine surgery: a prospective analysis. J Neurosurg Spine 2014; 21:698–703.
Yoshioka K, Murakami H, Demura S, et al. Comparative study of the prevalence of venous thromboembolism after elective spinal surgery. Orthopedics 2013; 36:e223–e228.
De la Garza Ramos R, Goodwin CR, Jain A, et al. Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) using a nationwide database and its association with inpatient morbidity, mortality, and length of stay after spine surgery. World Neurosurg 2016; 95:548–555.
Hill J, Treasure T, Guideline Development G. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart 2010; 96:879–882.
Glotzbecker MP, Bono CM, Wood KB, et al. Thromboembolic disease in spinal surgery: a systematic review. Spine (Phila Pa 1976) 2009; 34:291–303.
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e278S–e325S.
Luksanapruksa P, Buchowski JM, Zebala LP, et al. Perioperative complications of spinal metastases surgery. Clin Spine Surg 2017; 30:4–13.
Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults—United States, 2016. MMWR Morb Mortal Wkly Rep 2018; 67:53–59.
Kim DY, Kobayashi L, Chang D, et al. Early pharmacological venous thromboembolism prophylaxis is safe after operative fixation of traumatic spine fractures. Spine (Phila Pa 1976) 2015; 40:299–304.
Dhillon ES, Khanna R, Cloney M, et al. Timing and risks of chemoprophylaxis after spinal surgery: a single-center experience with 6869 consecutive patients. J Neurosurg Spine 2017; 27:681–693.
Amiri AR, Fouyas IP, Cro S, et al. Postoperative spinal epidural hematoma (SEH): incidence, risk factors, onset, and management. Spine J 2013; 13:134–140.
Glotzbecker MP, Bono CM, Wood KB, et al. Postoperative spinal epidural hematoma: a systematic review. Spine (Phila Pa 1976) 2010; 35:E413–E420.
Ahn DK, Shin WS, Kim GW, et al. Postoperative spinal epidural hematoma: the danger caused by the misuse of thrombin-containing local hemostatics. Asian Spine J 2017; 11:898–902.